Avantor completed the acquisition of Masterflex from GTCR and Golden Gate Capital-backed Antylia Scientific for $2.9bn.

Avantor, a global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, completed the acquisition of Masterflex, a global manufacturer of peristaltic pumps and aseptic single-use fluid transfer technologies, from GTCR and Golden Gate Capital-backed Antylia Scientific, a provider of peristaltic and single use bioprocessing solutions, for $2.9bn. "The acquisition of Masterflex reflects our commitment to the biopharma industry, and our ability to identify and execute on value-creation opportunities. The business enhances our portfolio of proprietary technologies and strengthens our position in the highest growth segments of the market. Both Avantor and Masterflex share a strong culture of innovation and excellence, and we look forward to welcoming Masterflex's highly skilled team to the Avantor family," Michael Stubblefield, Avantor President and CEO.